Effect of SynagisⓇ (palivizumab) prophylaxis on readmission due to respiratory syncytial virus in very low birth weight infants

• Main Authors: Soo Kyoung Park (Author), Yu Jin Jung (Author), Hye Soo Yoo (Author), So Yoon Ahn (Author), Hyun Joo Seo (Author), Seo Heui Choi (Author), Myo Jing Kim (Author), Ga Won Jeon (Author), Soo Hyun Koo (Author), Kyung-Hoon Lee (Author), Yun Sil Chang (Author), Won Soon Park (Author)
• Format: Book
• Published: Korean Pediatric Society, 2010-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Purpose : The aim of this study was to determine the efficacy of Synagis&amp&#59;#9415&#59; (palivizumab) in reducing the respiratory syncytial virus (RSV) readmission rate in very low birth weight infants (VLBWI ) and the subgroup that showed the most effective vaccination....